DANIELLE MCVEIGH: Open Payments
NPI 1699230193 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$747 in 40 payments from 13 companies in 2025. Trend: 2023 $722 · 2024 $840 · 2025 $747
Food & beverage: $747
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $234 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $115 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| Alnylam Pharmaceuticals Inc. | 3 | $56 |
| Abbott Laboratories | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 3 | $45 |
| Boston Scientific Corporation | 2 | $44 |
| SCPHARMACEUTICALS INC. | 1 | $35 |
| ABIOMED | 1 | $30 |
| AtriCure, Inc. | 1 | $26 |
Products named: LEQVIO, LifeVest, Kerendia, AMVUTTRA, CARDIOMEMS, FUROSCIX, CAMZYOS, SYNERGY ABLATION SYSTEM.
Industry payments across MS — which companies pay providers there.
